{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:53:15Z","timestamp":1781679195021,"version":"3.54.5"},"reference-count":19,"publisher":"Norwegian Medical Association","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2016,10,25]]},"DOI":"10.4045\/tidsskr.16.0308","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T07:23:33Z","timestamp":1477639413000},"page":"1639-42","source":"Crossref","is-referenced-by-count":1,"title":["Standardised detoxification in cases of polydrug use"],"prefix":"10.4045","volume":"136","author":[{"given":"Frode","family":"Duns\u00e6d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8istein","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-K\u00e5re","family":"Vederhus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Clausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnhild Mj\u00e5vatn","family":"H\u00f8ie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"McLellan AT, Lewis DC, O'Brien CP et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284: 1689\u2009\u2013\u200995. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11015800&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001\/jama.284.13.1689","DOI":"10.1001\/jama.284.13.1689"},{"key":"ref=2","unstructured":"WHO. Global health risks \u2013 mortality and burden of disease attributable to selected major risks.: www.who.int\/healthinfo\/global_burden_disease\/GlobalHealthRisks_report_full.pdf (12.3.2016)."},{"key":"ref=3","unstructured":"Hobbesland \u00c5. Unders\u00f8kelse av avgiftningsbehandling ved seks avgiftningsavdelinger i helseregion s\u00f8r. Skien: Borgestadklinikken, 2006."},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Shaygani S, Waal H. Behandling av opioid abstinens. Tidsskr Nor Legeforen 2009; 129: 114\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19151804&dopt=Abstract","DOI":"10.4045\/tidsskr.09.32466"},{"key":"ref=5","unstructured":"Helland A, Skj\u00f8tskift S. Medikamentell behandling av alkoholabstinens. Tidsskr Nor Laegeforen 2008; 128: 1182\u2009\u2013\u20094. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18480869&dopt=Abstract"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Parr JM, Kavanagh DJ, Cahill L et al. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction 2009; 104: 13\u2009\u2013\u200924. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18983627&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1360-0443.2008.02364.x","DOI":"10.1111\/j.1360-0443.2008.02364.x"},{"key":"ref=7","unstructured":"Nasjonal faglig retningslinje for avrusning fra rusmidler og vanedannende legemidler. https:\/\/helsedirektoratet.no\/retningslinjer\/avrusning-fra-rusmidler-og-vanedannende-legemidler (12.3.2016)."},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Kristensen \u00d8, L\u00f8landsmo T, Isaksen A et al. Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment. BMC Psychiatry 2006; 6: 54. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17107609&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186\/1471-244X-6-54","DOI":"10.1186\/1471-244X-6-54"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Paetzold W, Eronat V, Seifert J et al. Detoxifikation polytoxikomaner Patienten mit Buprenorphin. Nervenarzt 2000; 71: 722\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11042867&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s001150050656","DOI":"10.1007\/s001150050656"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Seifert J, Metzner C, Paetzold W et al. Detoxification of opiate addicts with multiple drug abuse: a\u00a0comparison of buprenorphine vs. methadone. Pharmacopsychiatry 2002; 35: 159\u2009\u2013\u200964. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12237786&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1055\/s-2002-34115","DOI":"10.1055\/s-2002-34115"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Ling W, Amass L, Shoptaw S et al. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 2005; 100: 1090\u2009\u2013\u2009100. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16042639&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1360-0443.2005.01154.x","DOI":"10.1111\/j.1360-0443.2005.01154.x"},{"key":"ref=12","unstructured":"Gowing L, Farrell MF, Ali R et al. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev 2014; 3: CD002024. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24683051&dopt=Abstract"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Minozzi S, Amato L, Vecchi S et al. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 2010; nr. 3: CD005064. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20238337&dopt=Abstract","DOI":"10.1002\/14651858.CD005064.pub3"},{"key":"ref=14","unstructured":"Saxon AJ, Whittaker S, Hawker CS. Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases. J Clin Psychiatry 1989; 50: 228\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2498296&dopt=Abstract"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Eyer F, Schreckenberg M, Hecht D et al. Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: a retrospective cohort study. Alcohol Alcohol 2011; 46: 177\u2009\u2013\u200984. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21339186&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093\/alcalc\/agr005","DOI":"10.1093\/alcalc\/agr005"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Nakken KO, Taub\u00f8ll E. Valproat b\u00f8r unng\u00e5s hos gravide. Tidsskr Nor Legeforen 2014; 134: 144\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24477142&dopt=Abstract","DOI":"10.4045\/tidsskr.13.1350"},{"key":"ref=17","unstructured":"Rusmiddelanalyser. Pr\u00f8vetaking, analyser og fortolkning. www.oslo-universitetssykehus.no\/omoss_\/avdelinger_\/farmakologi_\/Documents\/Rusmiddelheftet%20revidert%20101213%20%283%29.pdf. (12.3.2016)"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Ravndal E, Amundsen EJ. Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study. Drug Alcohol Depend 2010; 108: 65\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20022184&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.drugalcdep.2009.11.008","DOI":"10.1016\/j.drugalcdep.2009.11.008"},{"key":"ref=19","unstructured":"Nationella riktlinjer f\u00f6r missbruks- och beroendev\u00e5rd. www.socialstyrelsen.se\/Lists\/Artikelkatalog\/Attachments\/19770\/2015-4-2.pdf. (14.3.2016)"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Standardisert avrusning ved blandingsmisbruk"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:00:43Z","timestamp":1781676043000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2016\/10\/originalartikkel\/standardisert-avrusning-ved-blandingsmisbruk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,25]]},"references-count":19,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016,10,25]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.16.0308","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,25]]}}}